Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Pierluigi, Ballardini"'
Publikováno v:
International Medical Case Reports Journal, Vol 2012, Iss default, Pp 45-48 (2012)
International Medical Case Reports Journal
Scopus-Elsevier
International Medical Case Reports Journal
Scopus-Elsevier
Pierluigi Ballardini,1 Guido Margutti,1 Massimo Pedriali,2 Patrizia Querzoli21Department of Internal Medicine, Hospital of the Delta, Lagosanto, 2Institute of Pathology, S Anna Hospital, Ferrara, ItalyAbstract: Syringoid eccrine carcinoma is a very r
Publikováno v:
Clinical Drug Investigation. 29:487-490
Sunitinib is an orally administered multitargeted tyrosine kinase inhibitor that has demonstrated substantial antitumour activity in patients with metastatic renal cell carcinoma. The more common grade 3 or 4 adverse effects of sunitinib include hype
Publikováno v:
International Journal of Dermatology. 53:e180-e182
Publikováno v:
Current Oncology
Volume 18
Issue 3
Pages 782-110
Volume 18
Issue 3
Pages 782-110
The Editor, Current Oncology October 6, 2010 Re: Husein–ElAhmed H, Callejas–Rubio JL, Del Olmo RO, Rios–Fernandez R, Ortego–Centeno N. Severe Raynaud syndrome induced by adjuvant interferon alfa in metastatic melanoma. Curr Oncol 2010;17:122
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59aa21939818f22a4bb16e048c014553
http://hdl.handle.net/11392/1511120
http://hdl.handle.net/11392/1511120
Autor:
Giorgio Benea, Ivan Marri, Camillo Aliberti, Guido Margutti, Roberto Manfredini, Pierluigi Ballardini
Effective and safe systemic treatment for advanced hepatocellular carcinoma (HCC) with severe underlying cirrhosis is not yet available. Sorafenib, an oral multikinase inhibitor, has proved to be effective in the treatment of patients affected by HCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb2e370250c8d75c99806f04c29c7f9
http://hdl.handle.net/11392/1408610
http://hdl.handle.net/11392/1408610
Autor:
Giammaria, Fiorentini, Camillo, Aliberti, Alessandro, Del Conte, Massimo, Tilli, Susanna, Rossi, Pierluigi, Ballardini, Gina, Turrisi, Giorgio, Benea
Publikováno v:
In vivo (Athens, Greece). 23(1)
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults and the liver is the predominant site of metastases (LM). If metastases appear, none of the systemic treatments established for cutaneous melanoma so far have any signifi
Autor:
Elena Incasa, Susanna Gamberini, Silvia Marzocchi, Roberto Manfredini, Marilena Tampieri, Pierluigi Ballardini, Giorgio Benea, Arnaldo Zangirolami
Publikováno v:
The American journal of emergency medicine. 26(4)
Low back pain with sciatica is one of the most common complaints of patients presenting to the ED, and it is usually managed on an outpatient basis. However, acute lower back pain not always derives from a benign cause. We report here the case of a 6
Autor:
Pierluigi Ballardini, Carmine Pinto, Fabiola Lorena Rojas Llimpe, S. Giaquinta, G. Lelli, Anna Lisa Gentile, Andrea Martoni, Piana E, V. Mutri, Francesca Di Fabio
Publikováno v:
European journal of cancer (Oxford, England : 1990). 42(18)
This phase II randomised trial compares oxaliplatin plus protracted infusion of 5-fluorouracil (pviFOX) or oxaliplatin plus capecitabine (XELOX) in the first-line treatment of advanced colorectal cancer (ACRC). Methods: From December 2001 to March 20
Publikováno v:
Tumori. 91(6)
Mesenteric fibromatosis is a rare type of desmoid tumor characterized by local aggressiveness and a tendency to relapse. In view of these characteristics it may be considered a low-grade fibrosarcoma. Camurati-Engelmann disease is a very rare form of